Earnings Feed
Start Free
SUPERNUS PHARMACEUTICALS, INC.·4

Feb 24, 9:24 PM ET

Barlow Carrolee 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 24, 2022

Insider Transaction Report

Form 4
Period: 2022-02-22
SUPERNUS PHARMACEUTICALS, INC.SUPN
Barlow Carrolee
Director
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2022-02-22+6,847→ 6,847 total
    Exercise: $32.20From: 2023-02-22Exp: 2032-02-22→ Common Stock (6,847 underlying)
  • Award

    Restricted Stock Units

    2022-02-22+3,882→ 3,882 total
    → Common Stock (3,882 underlying)
Holdings

  • Common Stock

    9,433
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023.

Documents

2 files